Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

Intravascular near-infrared fluorescence and ultrasound coronary imaging

Project description

Molecular dimension in intravascular imaging

Intravascular ultrasound (IVUS) is a clinical imaging method that uses a miniature ultrasound probe inside blood vessels to visualise artery structure from within. It is widely used during procedures such as coronary stenting to guide treatment and assess plaque buildup. However, IVUS mainly shows vessel shape and cannot detect molecular biomarkers linked to vascular disease. The EIC-funded NIRFUS project addresses this limitation by combining IVUS with near-infrared fluorescence that can detect molecular signals. The research team will develop micro-optical components and advance hybrid catheters to enable reliable molecular imaging inside arteries. This breakthrough could significantly improve decision-making, outcomes, and cost-effectiveness in interventional cardiology.

Objective

NIRFUS will address the documented need of complementing morphology markers with patho-biological information during intravascular imaging. To enable molecular readings and achieve a breakthrough in interventional cardiology, NIRFUS will implement a new ability in medical micro-optics and address critical obstacles in catheter manufacturing and assembly precision. NIRFUS develops novel concepts and abilities in medical micro-optics by exploring advanced approaches for fabricating and aligning optical components, from basic principles to proof of concept and laboratory validation.
These novel methods will enable for the first time the development of clinical-grade near-infrared fluorescence (NIRF) readings added to intravascular ultrasound (IVUS), based on hybrid NIRF-IVUS catheters of unprecedented performance and reliability suitable for human use. NIRFUS will further add complimentary sensing modalities to deliver the most quantitative intravascular NIRF performance ever achieved. The advances in precision engineering, and optical integration, NIRFUS will lead to a new standard of medical micro-optics.
Likewise, the hybrid NIRF-IVUS catheter will lead to a new standard in interventional imaging and cardiology. NIRFUS may benefit 3 million people who undergo percutaneous coronary intervention (PCI) annually by radically improving treatment and clinical outcomes, as well as the efficiency and cost-effectiveness of the global interventional cardiology healthcare, with estimated cost savings of more than € 3.6 billion.

Fields of science (EuroSciVoc)

Keywords

Programme(s)

Topic(s)

Funding Scheme

HORIZON-EIC - HORIZON EIC Grants

See all projects funded under this funding scheme

Call for proposal

(opens in new window) HORIZON-EIC-2025-PATHFINDEROPEN

See all projects funded under this call

Coordinator

TECHNISCHE UNIVERSITAET MUENCHEN
Net EU contribution
€ 928 465,00
Address
Arcisstrasse 21
80333 Muenchen
Germany
Region
Bayern Oberbayern München, Kreisfreie Stadt
Activity type
Higher or Secondary Education Establishments
Links
Total cost
€ 928 465,00

Participants (4)